OBIO vs SRE · rev $198.0K vs P/E 31, rev $13.70B
Orchestra BioMed Holdings Inc. (OBIO) versus Sempra Energy (SRE) — a side-by-side from cached financials, not a winner call.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Sempra Energy (SRE) is a utilities - diversified company listed on US.
Latest reported OBIO revenue for 2026-06-30 was $198.0K. Net income was -$44.4M. Revenue was up 80.0% from 2026-03-31 to 2026-06-30. OBIO currently screens at market cap $231.7M.
Latest reported SRE revenue for 2025-12-31 was $13.70B. Net income was $1.84B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
OBIO currently screens at market cap $231.7M. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
Not investment advice. Open the OBIO and SRE stock pages for the full models.
Not investment advice.